In patients with clinical stage 1 (cT1) renal masses, many physicians opt for nephron-sparing surgery, such as partial nephrectomy (PN) versus radical nephrectomy (RN). Both procedures have been shown ...

Between 2009 and 2014 in Queensland, Australia, one in three patients whose kidney cancer was managed with radical nephrectomy developed ESKD, while one in 100 patients managed with partial ...

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

Cardiac transplant status is not significantly associated with adverse in-hospital outcomes in patients with kidney cancer ...

Evidence indicates that nephron-sparing surgery (NSS) can safely treat locally advanced renal cell carcinoma (RCC); however, few studies have assessed the safety and efficacy of NSS in patients with ...

Background. A 57-year-old woman presented to the emergency department at a community hospital with a 2-month history of fatigue and right-sided flank and abdominal pain. Noncontrast CT of the abdomen ...

Comparative effectiveness of front-line agents in the treatment of metastatic clear cell renal cell carcinoma. International, expanded access program of everolimus in patients with metastatic renal ...

Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study. This is an ASCO Meeting Abstract from the 2014 Genitourinary Cancers ...

Various factors, like disease subtype, genetics and stage can all play into the treatment of kidney cancer. Types of treatment for kidney cancer consist of surgery, ablation and other local therapy, ...